A mathematical model quantifies proliferation and motility effects of TGF-β on cancer cells

Computational and Mathematical Methods in Medicine

Volumn 10, Issue 1, 2009, Pages 71-83

  Wang, Shizhen Emily ^a   Hinow, Peter ^b   Bryce, Nicole ^a   Weaver, Alissa M ^a   Estrada, Lourdes ^a   Arteaga, Carlos L ^a   Webb, Glenn F ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Cell growth and motility; Fisher Kolmogorov equation; Mathematical model; Transforming growth factor (TGF) beta;

Indexed keywords

CELL ADHESION; CELL PROLIFERATION; COMPUTATIONAL COMPLEXITY; MATHEMATICAL MODELS; POPULATION STATISTICS; TUMORS;

CELL-CELL ADHESION; FISHER-KOLMOGOROV EQUATIONS; HUMAN MAMMARY EPITHELIAL CELLS; MODELLING AND EXPERIMENTS; POPULATION GROWTH; SIMULTANEOUS EFFECTS; TRANSFORMING GROWTH FACTORS; TUMOUR SUPPRESSOR;

CELLS;

EID: 62149139082     PISSN: 1748670X     EISSN: 17486718     Source Type: Journal    
DOI: 10.1080/17486700802171993     Document Type: Article

References (42)

1. Anderson, A. R. A. (2005) A hybrid mathematical model of solid tumour invasion: The importance of cell adhesion. IMA Math. Appl. Med. Biol., 22, pp. 163-186.
2. Ayati, B. P., Webb, G. F. and Anderson, A. R. A. (2006) Computational methods and results for structured multiscale models of tumor invasion. Multiscale Model. Simul., 5, pp. 1-20.
3. Berg, H. C. (1983) Random Walks in Biology, Princeton University Press, Princeton, NJ
4. Bray, D. (1992) Cell Movements, Garland Publishing, New York
5. Chaplain, M. A. J. and Anderson, A. R. A. (1998) Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol., 60, pp. 857-899.
6. Chaplain, M. A. J. and Matzavinos, A. (2006) Mathematical modelling of spatio-temporal phenomena in tumour immunology. A. Friedman: Tutorials in mathematical biosciences, III, Lecture Notes in Mathematics, 1872, pp. 131-183. Springer Verlag, Berlin, NY
7. Derynck, R., Akhurst, R. J. and Balmain, A. J. (2001) TGF-β signaling in tumor suppression and cancer progression. Nat. Genet., 29, pp. 117-129.
8. Drasdo, D. and Hohme, S. (2003) Individual-based approaches to birth and death in avascular tumors. Math. Comput. Model., 37, pp. 1163-1175.
9. Dumont, N. and Arteaga, C. L. (2003) Targeting the TGF β signaling network in human neoplasia. Cancer Cell, 3, pp. 531-536.
10. Enderling, H., Chaplain, M. A. J., Anderson, A. R. A. and Vaidya, J. S. (2007) A mathematical model of breast cancer development, local treatment and recurrence. J. Theor. Biol., 246, pp. 245-259.
11. Ewan, K. B. et al. (2002) Latent transforming growth factor-β activation in mammary gland: Regulation by ovarian hormones affects ductal and alveolar proliferation. Am. J. Pathol., 160, pp. 2081-2093.
12. Fisher, R. A. (1937) The wave of advance of advantageous genes. Ann. Eugenics, 7, pp. 355-369.
13. Gobbi, H. et al. (1998) Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res., 58, pp. 5329-5332.
14. Goggins, M. et al. (1998) Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res., 58, pp. 5329-5332.
15. Goggins, M. et al. (1999) Transforming growth factor β and breast cancer risk in women with mammary epithelial hyperplasia. J. Natl Cancer Inst., 91, pp. 2096-2101.
16. Hahn, S. A. et al. (1996) Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res., 56, pp. 490-494.
17. Hinow, P. et al. (2007) A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor. Theor. Biol. Med. Model., 4, p. 14.
18. Kolmogorov, A. N., Petrovskii, I. G. and Piskunov, N. S. (1937) A study of the equation of diffusion with increase in the quantity of matter, and its application to a biological problem. Bull. Moscow Univ., 1, pp. 1-25.
19. Lefever, R. and Erneaux, T. (1984) On the growth of cellular tissues under constant and fluctuating environmental conditions. Nonlinear Electrodynamics in Biological Systems, pp. 287-305. Plenum Press, New York
20. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sua, L. -Z., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M. and Willson, J. K. V. (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 268, pp. 1336-1338.
21. Massague, J. (1998) TGF-β signal transduction. Annu. Rev. Biochem., 67, pp. 753-791.
22. Massague, J. and Chen, Y. G. (2000) Controlling TGF-β signaling. Genes Dev., 14, pp. 627-644.
23. Moses, H. L. et al. (1981) Transforming growth factor production by chemically transformed cells. Cancer Res., 41, pp. 2842-2848.
24. Muraoka-Cook, R. S., Dumont, N. and Arteaga, C. L. (2005) Dual role of transforming growth factor β in mammary tumorigenesis and metastatic progression. Clin. Cancer Res., 11, pp. 937s-943s.
25. Muraoka-Cook, R. S. et al. (2006) Activated type ITGF β receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression. Oncogene, 25, pp. 3408-3423.
26. Muraoka, R. S. et al. (2003) Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor β 1. Mol. Cell. Biol., 23, pp. 8691-8703.
27. Nawshad, A. et al. (2005) Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: Implications for embryogenesis and tumor metastasis. Cells Tissues Organs, 179, pp. 11-23.
28. Press, W. H. et al. (1988) Numerical Recipes in C, Cambridge University Press, Cambridge
29. Prigogine, I. and Lefever, R. (1980) Stability problems in cancer growth and nucleation. Comp. Biochem. Physiol., 67, pp. 389-393.
30. Qian, H., Sheetz, M. P. and Elson, E. L. (1991) Single particle tracking. Analysis of diffusion and flow in two-dimensional systems. Biophys. J., 60, pp. 910-921.
31. Roberts, A. B. et al. (1985) Type β transforming growth factor: A bifunctional regulator of cellular growth. Proc. Natl Acad. Sci. U S A, 82, pp. 119-123.
32. Selmeczi, D. et al. (2005) Cell motility as persistent random motion: Theories from experiments. Biophys. J., 89, pp. 912-931.
33. Seton-Rogers, S. E. et al. (2004) Cooperation of the ErbB2 receptor and transforming growth factor β in induction of migration and invasion in mammary epithelial cells. Proc. Natl Acad. Sci. U S A, 101, pp. 1257-1262.
34. Siegel, P. M. and Massague, J. (2003) Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer, 3, pp. 807-821.
35. Tucker, R. F. et al. (1984) Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science, 226, pp. 705-707.
36. Turner, S., Sherratt, J. A. and Cameron, D. (2004) Tamoxifen treatment failure in cancer and the nonlinear dynamics of TGF-β. J. Theor. Biol., 229, pp. 101-111.
37. Ueda, Y. et al. (2004) Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor β-induced cell motility. J. Biol. Chem., 279, pp. 24505-24513.
38. Wakefield, L. M. and Roberts, A. B. (2002) TGF-β signaling: Positive and negative effects on tumorigenesis. Curr. Opin. Genet Dev., 12, pp. 22-29.
39. Wang, D. et al. (1995) Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270, pp. 22044-22049.
40. Wang, J. (2000) Analysis of specific gene mutations in the transforming growth factor-β signal transduction pathway in human ovarian cancer. Cancer Res., 60, pp. 4507-4512.
41. Wang, S. E. (2006) HER2/Neu (ErbB2) signaling to rac1-pak1 is temporally and spatially modulated by transforming growth factor β. Cancer Res., 66, pp. 9591-9600.
42. Yang, Y. A. et al. (2002) Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects. J. Clin. Invest., 109, pp. 1607-1615.